Interfaith Center on Corporate Responsibility: Investors Urge 'No' Vote on Revised NAFTA Agreement
September 12, 2019
September 12, 2019
NEW YORK, Sept. 12 -- The Interfaith Center on Corporate Responsibility issued the following news release:
* * *
- Citing concerns that NAFTA 2.0 will expand prescription drug monopoly protections and drive up drug prices by thwarting competition, investors urge lawmakers to vote 'no' on current agreement.
* * *
Members of the Interfaith Center on Corporate Responsibility (ICCR) sent a letter to the U.S. Congress today urging a "no" v . . .
* * *
- Citing concerns that NAFTA 2.0 will expand prescription drug monopoly protections and drive up drug prices by thwarting competition, investors urge lawmakers to vote 'no' on current agreement.
* * *
Members of the Interfaith Center on Corporate Responsibility (ICCR) sent a letter to the U.S. Congress today urging a "no" v . . .